Geode Capital Management LLC Sells 12,331 Shares of PetMed Express, Inc. (NASDAQ:PETS)

Geode Capital Management LLC decreased its stake in shares of PetMed Express, Inc. (NASDAQ:PETS) by 5.3% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 221,230 shares of the company’s stock after selling 12,331 shares during the quarter. Geode Capital Management LLC’s holdings in PetMed Express were worth $814,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Federated Hermes Inc. increased its stake in PetMed Express by 54.5% in the second quarter. Federated Hermes Inc. now owns 606,430 shares of the company’s stock valued at $2,456,000 after acquiring an additional 213,903 shares during the period. Cubist Systematic Strategies LLC bought a new stake in PetMed Express in the second quarter valued at about $797,000. Bleakley Financial Group LLC bought a new stake in PetMed Express in the third quarter valued at about $279,000. Squarepoint Ops LLC bought a new stake in PetMed Express in the second quarter valued at about $273,000. Finally, Sei Investments Co. increased its stake in PetMed Express by 8.3% in the second quarter. Sei Investments Co. now owns 44,220 shares of the company’s stock valued at $179,000 after acquiring an additional 3,400 shares during the period. Institutional investors own 73.33% of the company’s stock.

Insider Buying and Selling at PetMed Express

In related news, Director Leslie C.G. Campbell bought 15,000 shares of PetMed Express stock in a transaction dated Wednesday, December 4th. The shares were bought at an average cost of $5.38 per share, for a total transaction of $80,700.00. Following the completion of the transaction, the director now owns 70,000 shares of the company’s stock, valued at approximately $376,600. This trade represents a 27.27 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 1.10% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com raised shares of PetMed Express from a “hold” rating to a “buy” rating in a research note on Tuesday, November 12th.

PetMed Express Stock Down 0.2 %

NASDAQ:PETS opened at $4.77 on Friday. The firm has a market cap of $98.56 million, a PE ratio of -79.50 and a beta of 0.69. PetMed Express, Inc. has a 12 month low of $2.90 and a 12 month high of $7.40. The company’s 50-day moving average price is $5.04 and its two-hundred day moving average price is $4.15.

PetMed Express (NASDAQ:PETS) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.11 EPS for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.17. The firm had revenue of $59.57 million for the quarter, compared to analyst estimates of $66.02 million. PetMed Express had a negative net margin of 0.37% and a negative return on equity of 1.00%. On average, research analysts expect that PetMed Express, Inc. will post 0.24 EPS for the current fiscal year.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.